| Literature DB >> 30963976 |
Giovanna Muscogiuri1, Luigi Barrea1, Barbara Altieri1, Carolina Di Somma2, Harjit Pal Bhattoa3, Daniela Laudisio1, Guillaume T Duval4, Gabriella Pugliese1, Cédric Annweiler4,5, Francesco Orio6, Hana Fakhouri7, Silvia Savastano1, Annamaria Colao1.
Abstract
Vitamin D and calcium are considered crucial for the treatment of bone diseases. Both vitamin D and calcium contribute to bone homeostasis but also preserve muscle health by reducing the risk of falls and fractures. Low vitamin D concentrations result in secondary hyperparathyroidism and contribute to bone loss, although the development of secondary hyperparathyroidism varies, even in patients with severe vitamin D deficiency. Findings from observational studies have shown controversial results regarding the association between bone mineral density and vitamin D/calcium status, thus sparking a debate regarding optimum concentrations of 25-hydroxyvitamin D and calcium for the best possible skeletal health. Although most of the intervention studies reported a positive effect of supplementation with calcium and vitamin D on bone in patients with osteoporosis, this therapeutic approach has been a matter of debate regarding potential side effects on the cardiovascular (CV) system. Thus, the aim of this review is to consider the current evidence on the physiological role of vitamin D and calcium on bone and muscle health. Moreover, we provide an overview on observational and interventional studies that investigate the effect of vitamin D and calcium supplementation on bone health, also taking into account the possible CV side-effects. We also provide molecular insights on the effect of calcium plus vitamin D on the CV system. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Vitamin D; bone health; calcium; cardiovascular system; myocardial infarction; stroke.
Mesh:
Substances:
Year: 2019 PMID: 30963976 DOI: 10.2174/1570161117666190408165805
Source DB: PubMed Journal: Curr Vasc Pharmacol ISSN: 1570-1611 Impact factor: 2.719